• 1
    Global Alliance Against Chronic Respiratory Diseases (GARD). A comprehensive for the global surveillance, prevention and control of chronic respiratory diseases and for decreasing their burden. Geneva: World Health Organization, 2006.
  • 2
    Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469478.
  • 3
    Burney P. Variations in the prevalence of respiratory symptoms, self-report asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996;9:687695.
  • 4
    The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:12251232.
  • 5
    Zacharasiewicz A, Douwes J, Pearce N. What proportion of rhinitis symptoms is attributable to atopy? J Clin Epidemiol 2003;56:385390.
  • 6
    Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004;24:758764.
  • 7
    Sunyer J, Jarvis D, Pekkanen J, Chinn S, Janson C, Leynaert B et al. Geographic variations in the effect of atopy on asthma in the European Community Respiratory Health Study. J Allergy Clin Immunol 2004;114:10331039.
  • 8
    Strachan D, Sibbald B, Weiland S, Ait-Khaled N, Anabwani G, Anderson HR et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997;8:161176.
  • 9
    Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733743.
  • 10
    The European Community Respiratory Health Survey. Medicine and health. Luxembourg: European Commission, Directorate General XIII, Office for Offical Publications L-2920, 1994.
  • 11
    Droste JH, Kerhof M, De Monchy JG, Schouten JP, Rijcken B. Association of skin test reactivity, specific IgE, total IgE, and eosinophils with nasal symptoms in a community-based population study. The Dutch ECRHS Group. J Allergy Clin Immunol 1996;97:922932.
  • 12
    Chinn S, Jarvis D, Luczynska CM, Lai E, Burney PG. Measuring atopy in a multi-centre epidemiological study. Eur J Epidemiol 1996;12:155162.
  • 13
    Bousquet PJ, Hooper R, Kogevinas M, Jarvis D, Burney P. Number of allergens to be tested to assess allergenic sensitization in epidemiologic studies: results of the European Community Respiratory Health Survey I. Clin Exp Allergy 2007;37:780787.
  • 14
    Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics 1993;49:865872.
  • 15
    Wacholder S, Benichou J, Heineman EF, Hartge P, Hoover RN. Attributable risk: advantages of a broad definition of exposure. Am J Epidemiol 1994;140:303309.
  • 16
    Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994;7:954960.
  • 17
    Demoly P, Bousquet J, Manderscheid JC, Dreborg S, Dhivert H, Michel FB. Precision of skin prick and puncture tests with nine methods see comments. J Allergy Clin Immunol 1991;88:758762.
  • 18
    Demoly P, Piette V, Bousquet J. In vivo methods for study allergy. In: AdkinsonN, YungingerJ, BusseW, BochnerB, HolgateS, SimonsF, editors. Middleton’s allergy principles and practice, 6th edn. Philadelphia, PA: Mosby, 2003:631643.
  • 19
    Svanes C, Jarvis D, Chinn S, Omenaas E, Gulsvik A, Burney P. Early exposure to children in family and day care as related to adult asthma and hay fever: results from the European Community Respiratory Health Survey. Thorax 2002;57:945950.
  • 20
    Charpin D, Calleja M, Lahoz C, Pichot C, Waisel Y. Allergy to cypress pollen. Allergy 2005;60:293301.
  • 21
    Jarvis D, Luczynska C, Chinn S, Potts J, Sunyer J, Janson C et al. Change in prevalence of IgE sensitization and mean total IgE with age and cohort. J Allergy Clin Immunol 2005; 116: 675682.
  • 22
    Rondon C, Romero JJ, Lopez S, Antunez C, Martin-Casanez E, Torres MJ et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol 2007;119:899905.
  • 23
    Walter SD. Effects of interaction, confounding and observational error on attributable risk estimation. Am J Epidemiol 1983;117:598604.
  • 24
    Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104:301304.
  • 25
    Bachert C, Van Cauwenberge P, Olbrecht J, Van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006;61:693698.
  • 26
    Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108:S147S334.